Outlook for U.S. Entitlement Spending Among Government Cuts

Apr. 08, 2025 - 2 minutes
Two medical professionals walking together while in a discussion.

Overview:

  • The re-election of President Trump and the latest House budget resolution are contributing to talks of material cuts to healthcare entitlements, primarily Medicaid.
  • Medicaid covers 79 million people, including 47% of all U.S. children across a diverse mix of states.
  • We do not believe there is congressional consensus nor yet a financial imperative to materially reduce U.S. healthcare entitlement programs.
  • Barring a borrowing crisis, our stress-test identifies 2030 to 2035 as the earliest plausible period in which Congress would be compelled to make material cuts.

U.S. Healthcare Models Highlight Federal Budget Stress and Medicaid Exposure

We built a comprehensive, interactive U.S. healthcare entitlement "stress-test" model. This model utilizes key demographic, tax, interest rate and GDP variables in order to identify periods of maximum federal budget stress. We also built a comprehensive state Medicaid exposure model. We compiled in a single, sortable format by state: the total Medicaid enrollment, penetration, spending, per capita, per enrollee, federal matching percentage, total federal balance of payments, state directed payment reimbursement and publicly-traded hospital exposure. Additionally, we compiled and reviewed historical healthcare entitlement reduction efforts, comparing and contrasting with the current fiscal and political environment.

Funding versus "Rate" Cut

We note the proposed Medicaid cuts are to funding and not to Medicaid rate but could functionally have a similar impact in the short-term. We see three broad categories of potential impact:

  1. changes in eligibility and enrollment,
  2. changes in the scope of covered services, and
  3. reductions in programmatic funding.

Financial & Industry Model Implications

The possible Medicaid funding/enrollment reductions outlined herein would negatively impact nearly every payer and provider in our coverage. Hospitals are potentially exposed to multiple avenues of funding reductions, and some have traded off nearly -20% since the election. Medicaid managed care organizations (MCOs) are exposed to potential degradation in the risk pools related to enrollment reforms, but funding reduction exposure appears more moderate. We have included a sensitivity analysis of the following:

  • the EPS impact to payers, and
  • EBITDA impact to providers.

What to Watch

Watch for creative accounting gimmicks in the Senate to elude reconciliation requirements that fiscal measures do not contribute to the Federal deficit beyond a ten-year window. House Energy & Commerce and Senate Finance are the key committees with jurisdiction over Medicaid spending.

Subscribing clients can read the full report, The Sun Never Sets - Ahead Of The Curve, on the TD One Portal

The views or opinions expressed herein represent the personal views of the writer and do not necessarily reflect the views of TD Securities or its affiliates.

This material is intended to provide commentary on the market for commodities discussed herein.

Not Advice: The information contained in this material is for informational purposes only and is not intended to provide professional, investment or any other type of advice or recommendation, or to create a fiduciary relationship. Neither TD Securities (USA) LLC (“TD Securities USA”) nor any of its affiliates (collectively, “TD”) makes any representation or warranty, express or implied, regarding the accuracy, reliability, completeness, appropriateness or sufficiency for any purpose of any information included in this material. Certain information may have been provided by third-party sources and, while believed to be reliable, has not been independently verified by TD, and its accuracy or completeness acannot be guaranteed. You should not make an investment decision in reliance on this material, which is intended to provide only brief comments on the topics addressed, and is based on information that is likely to change without notice.

Not Securities or Derivatives Research: This material has not been produced, reviewed or approved by TD’s securities or derivatives research departments. The views of the author may differ from others at TD, including TD securities or derivatives research analysts.

Not Independent: The views expressed in this material may not be independent of the interests of TD. TD may engage in conflicting activities, including principal trading before or after posting this material, or other services involving commodities discussed in this material, or related financial products. TD may have a financial interest in the commodities discussed in this material, including, without limitation, a financial product that references such commodities.

Not An Offer or Solicitation: Nothing contained in this material is, or should be construed as, an offer, a solicitation of an offer or an invitation to buy or sell any commodity, or any financial product that references such commodity, and it is not intended for distribution in any jurisdiction where such distribution would be contrary to law.

Risk of Loss. Transactions in commodities, and financial instruments that reference commodities, involve risk of loss, and are subject to the risks of fluctuating prices. You should weigh potential benefits against the risks. Past performance is no indicator of future performance and the Materials are not intended to forecast or predict future events.


Portrait of Gary Taylor

Managing Director, Health Care - Facilities & Managed Care Research Analyst, TD Cowen

Portrait of Gary Taylor


Managing Director, Health Care - Facilities & Managed Care Research Analyst, TD Cowen

Portrait of Gary Taylor


Managing Director, Health Care - Facilities & Managed Care Research Analyst, TD Cowen

Gary Taylor is a managing director and senior equity research analyst covering healthcare facilities, managed care, and emerging payor/providers. His sector coverage includes large-cap legacy health insurance companies, inpatient and outpatient healthcare providers, and emerging disruptive payors and risk-based providers.

Mr. Taylor joined TD Cowen in 2021 after covering the sector for 22 years at JP Morgan, Citigroup, and Banc of America Securities. Previously, he worked in the healthcare services sector as an investment banker and hospital reimbursement consultant. For two decades, Mr. Taylor has been continuously recognized as one of the top analysts in his sector by Institutional Investor magazine.

He earned a BHS, MBA, and MHA, all from the University of Missouri.

Portrait of Ryan Langston

Vice President, Health Care - Health Care Facilities/Providers, Managed Care, and Emerging Payor/Providers Research Analyst, TD Cowen

Portrait of Ryan Langston


Vice President, Health Care - Health Care Facilities/Providers, Managed Care, and Emerging Payor/Providers Research Analyst, TD Cowen

Portrait of Ryan Langston


Vice President, Health Care - Health Care Facilities/Providers, Managed Care, and Emerging Payor/Providers Research Analyst, TD Cowen

Ryan Langston is a Vice President covering Health Care Facilities/Providers, Managed Care, and Emerging Payor/Providers. Prior to joining TD Cowen in 2021, he held several leadership positions including Vice President of Business Strategy for a metals manufacturer and was the CFO of 2 acute care hospitals for a regional health system. He also worked in equity research at Citigroup from 2008-2014.

Mr. Langston has a BS in Communications from SUNY Fredonia, and also received an MBA in Professional Accounting and an MBA in Finance, both from the Richard J. Wehle School of Business at Canisius University.

Portrait of Rick Weissenstein

Managing Director, Washington Research Group - Health Care Services & Pharmaceutical Policy Analyst, TD Cowen

Portrait of Rick Weissenstein


Managing Director, Washington Research Group - Health Care Services & Pharmaceutical Policy Analyst, TD Cowen

Portrait of Rick Weissenstein


Managing Director, Washington Research Group - Health Care Services & Pharmaceutical Policy Analyst, TD Cowen

Rick Weissenstein joined TD Cowen Washington Research Group in August 2016 and covers health care services policy issues. TD Cowen Washington Research Group was recently named #1 in the Institutional Investor Washington Strategy category. The team has been consistently ranked among the top macro policy teams for the past decade. Previously he worked as a senior analyst at Guggenheim Securities, MF Global, Stanford Financial, and Schwab Soundview, where he was responsible for analyzing health care policy issues and emerging trends in the federal and state legislative, regulatory, and legal arenas and their implications for the health care industry.

He was formerly the Washington Bureau Chief for Modern Healthcare magazine, and a reporter for Advertising Age magazine. Mr. Weissenstein began his career as a Certified Public Accountant in the Chicago office of Ernst & Young. He earned a bachelor’s degree in accounting at Millikin University, and a master’s degree in journalism at the University of Illinois, Champaign-Urbana.

Material prepared by the TD Cowen Washington Research Group is intended as commentary on political, economic, or market conditions and is not intended as a research report as defined by applicable regulation.